Our Mission

Our Purpose at SKAI MED

---

Vascular disease kills silently. Arterial plaque, blood-flow impairment, and progressive arterial stiffening are largely asymptomatic — often undetected until a stroke occurs, a dialysis fistula fails, or a prevention window closes permanently.

The problem is rarely a lack of treatment. It is a lack of timely detection — and a lack of practical tools to screen at the scale and in the settings where risk actually lives.

SKAI MED exists to shift that equation. We believe early vascular detection and data-driven clinical insight should be accessible, affordable, and scalable — not limited by cost, complexity, or specialist availability.

What We Screen For

SKAI-Touch, our flagship platform, is purpose-built for three vascular screening applications — each addressing a distinct clinical or wellness gap that existing tools cannot fill practically or affordably.

Stroke Risk Triage - Rapid carotid artery screening to detect plaque presence and flag individuals for confirmatory follow-up, enabling earlier intervention in primary care and community settings.

Dialysis AV Fistula Monitoring - Non-invasive fistula blood-flow assessment for dialysis centers, supporting routine monitoring without specialist referral or additional imaging.

Artery Fitness Screening - Pulse wave analysis benchmarked against VO2max levels to reveal true arterial age — a concrete, data-driven measure of vascular health that goes beyond physical age and beyond what any standard health check currently provides.

Our goal is to empower clinicians, healthcare providers, and individuals with tools that make preventive healthcare practical, reliable, and widely accessible.

How We Work With Partners

SKAI MED's vascular screening technology is designed to be deployed at scale — and we work with partners in three ways depending on their needs, infrastructure, and goals. Whether you are looking to integrate our platform into your clinical workflow, build around our technology, or generate the evidence base for adoption in your market, there is a structured path to work with us.

---

1. License & Deploy
For hospitals, healthcare networks, and medical device companies ready to bring vascular screening capability into their settings or products. We license our proprietary sensing platform, AI analytics engine, and clinical software — with implementation support, continuous software updates, and a roadmap for expanding applications as our clinical dataset grows. You get a validated, deployable system without building the core technology from scratch.

2. Validate & Expand
For research institutions, clinical partners, and healthcare organizations looking to generate local evidence, explore new applications, or accelerate regulatory pathways in their market. We provide end-to-end clinical study support — protocol design, data workflows, biosignal analysis, and conversion of raw measurements into clinically meaningful endpoints. Every validation partnership also strengthens the underlying AI model, benefiting the entire platform.

3. Build & Integrate
For partners with specific clinical, operational, or product requirements that go beyond off-the-shelf deployment. We work collaboratively to design and integrate vascular screening capability into custom workflows, devices, or health platforms — translating your clinical and technical goals into a working, deployable solution. This is the right path for partners who need the technology shaped to their context rather than adopted as-is.